Lykke Ørnbjerg
0000-0002-7832-6831
10 papers found
Refreshing results…
Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries
One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment
Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care: characteristics and predictors
Conversion of the MDHAQ to the HAQ score: a simple algorithm developed and validated in a cohort of 13 391 real-world patients
EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology
European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response
Analysing and reporting of observational data: a systematic review informing the EULAR points to consider when analysing and reporting comparative effectiveness research with observational data in rheumatology
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration
Soluble CD206 plasma levels in rheumatoid arthritis reflect decrease in disease activity
Missing publications? Search for publications with a matching author name.